A22G (p.Ala22Gly) variant of AGT (Angiotensinogen)

A22G (p.Ala22Gly) in AGT (Angiotensinogen) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes population frequency data and structural context.

A22G (p.Ala22Gly) variant details